These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7476236)

  • 1. Exploitation of parasite derived antigen in therapeutic success of human cutaneous leishmaniasis in Brazil.
    Monjour L; Neogy AB; Vouldoukis I; Silva OA; Boisnic S; Brito ME; Lesot A; Vignot N; Martins JS; Jardim ML
    Mem Inst Oswaldo Cruz; 1994; 89(3):479-83. PubMed ID: 7476236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy.
    Ferraz R; Cunha CF; Gomes-Silva A; Schubach AO; Pimentel MI; Lyra MR; Mendonça SC; Valete-Rosalino CM; Da-Cruz AM; Bertho ÁL
    BMC Infect Dis; 2015 Feb; 15():74. PubMed ID: 25870976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3
    Ferraz R; Cunha CF; Pimentel MIF; Lyra MR; Pereira-Da-Silva T; Schubach AO; Da-Cruz AM; Bertho AL
    Parasit Vectors; 2017 May; 10(1):219. PubMed ID: 28468680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
    Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
    Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis.
    Carvalho EM; Correia Filho D; Bacellar O; Almeida RP; Lessa H; Rocha H
    Am J Trop Med Hyg; 1995 Sep; 53(3):273-7. PubMed ID: 7573712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potentially diagnostic Leishmania braziliensis antigens in human cutaneous leishmaniasis by immunoblot analysis.
    Brito ME; Mendonça MG; Gomes YM; Jardim ML; Abath FG
    Clin Diagn Lab Immunol; 2000 Mar; 7(2):318-21. PubMed ID: 10702514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.
    Valli LC; Passos VM; Dietze R; Callahan HL; Berman JD; Grogl M
    J Parasitol; 1999 Dec; 85(6):1076-83. PubMed ID: 10647040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
    Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
    PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania braziliensis-reactive T cells are down-regulated in long-term cured cutaneous Leishmaniasis, but the renewal capacity of T effector memory compartments is preserved.
    Pereira-Carvalho R; Mendes-Aguiar CO; Oliveira-Neto MP; Covas CJ; Bertho AL; Da-Cruz AM; Gomes-Silva A
    PLoS One; 2013; 8(11):e81529. PubMed ID: 24303052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of flow cytometry and qPCR to study the immune response of american cutaneous leishmaniasis patients.
    Brelaz-de-Castro MCA; de Almeida TM; de Almeida AF; de Assis Souza M; de Oliveira Mendes AP; Silva RFE; de Brito MEF; Pereira VRA
    Microb Pathog; 2018 Oct; 123():433-439. PubMed ID: 30076983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Leishmania-specific T cells in human American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) by limiting dilution analysis.
    Dórea RC; Coutinho SG; Sabroza PC; Hendriks J; Cysne L; Conceição-Silva F
    Clin Exp Immunol; 1988 Jan; 71(1):26-31. PubMed ID: 3258203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis.
    Conceição-Silva F; Dórea RC; Pirmez C; Schubach A; Coutinho SG
    Clin Exp Immunol; 1990 Feb; 79(2):221-6. PubMed ID: 2311299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of the antibody response in patients with therapeutic or spontaneous cure of American cutaneous leishmaniasis.
    Brito ME; Mendonça MG; Gomes YM; Jardim ML; Abath FG
    Trans R Soc Trop Med Hyg; 2001; 95(2):203-6. PubMed ID: 11355562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure.
    Brelaz-de-Castro MC; de Almeida AF; de Oliveira AP; de Assis-Souza M; da Rocha LF; Pereira VR
    Cell Immunol; 2012 Oct; 279(2):180-6. PubMed ID: 23246680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania (Viannia) braziliensis: epidemiology of canine cutaneous leishmaniasis in the State of Paraná (Brazil).
    Castro EA; Thomaz-Soccol V; Augur C; Luz E
    Exp Parasitol; 2007 Sep; 117(1):13-21. PubMed ID: 17449032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmaniasis recidiva cutis in American cutaneous leishmaniasis.
    Bittencourt AL; Costa JM; Carvalho EM; Barral A
    Int J Dermatol; 1993 Nov; 32(11):802-5. PubMed ID: 8270337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.